A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
Clinical trial NCT07595913 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07595913
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-06-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.